CELL Technologies Inc.

Quick facts

Phase 3 pipeline

• Autologous Bone Marrow Aspirate Concentrate · Regenerative Medicine; Orthopedics; Musculoskeletal
  Autologous bone marrow aspirate concentrate delivers a patient's own bone marrow-derived cells (including mesenchymal stem cells and hematopoietic progenitors) to promote tissue repair and reduce inflammation.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• CELL Technologies Inc. portfolio CI brief
• CELL Technologies Inc. pipeline updates RSS